Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125441691 | 12544169 | 1 | I | 20160703 | 20160711 | 20160711 | EXP | DK-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023573 | GLENMARK | JORGENSEN J.S, LANDSCHOFF LASSEN L AND WEGENER M.. LITHIUM-INDUCED DOWNBEAT NYSTAGMUS AND HORIZONTAL GAZE PALSY.. OPEN OPHTHALMOLOGY JOURNAL.. 2016;10:126-128 | 62.00 | YR | F | Y | 0.00000 | 20160711 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125441691 | 12544169 | 1 | PS | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | Unknown | 600 MG, QD | Y | 79139 | 600 | MG | |||||||
| 125441691 | 12544169 | 2 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | 75 MG, QD | 0 | 75 | MG | ||||||||
| 125441691 | 12544169 | 3 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 0 | ||||||||||||
| 125441691 | 12544169 | 4 | C | VALPROATE | VALPROIC ACID | 1 | Unknown | 1500 MG, QD | 0 | 1500 | MG | ||||||||
| 125441691 | 12544169 | 5 | C | VALPROATE | VALPROIC ACID | 1 | 0 | ||||||||||||
| 125441691 | 12544169 | 6 | C | VENLAFAXIN | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 375 MG, QD | 0 | 375 | MG | ||||||||
| 125441691 | 12544169 | 7 | C | VENLAFAXIN | VENLAFAXINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125441691 | 12544169 | 1 | Bipolar disorder |
| 125441691 | 12544169 | 2 | Epilepsy |
| 125441691 | 12544169 | 3 | Depression |
| 125441691 | 12544169 | 4 | Depression |
| 125441691 | 12544169 | 5 | Epilepsy |
| 125441691 | 12544169 | 6 | Depression |
| 125441691 | 12544169 | 7 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125441691 | 12544169 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125441691 | 12544169 | Asthenia | |
| 125441691 | 12544169 | Ataxia | |
| 125441691 | 12544169 | Cognitive disorder | |
| 125441691 | 12544169 | Diplopia | |
| 125441691 | 12544169 | Fall | |
| 125441691 | 12544169 | Gait disturbance | |
| 125441691 | 12544169 | Gaze palsy | |
| 125441691 | 12544169 | Nystagmus | |
| 125441691 | 12544169 | Retrograde amnesia | |
| 125441691 | 12544169 | Saccadic eye movement | |
| 125441691 | 12544169 | Toxicity to various agents | |
| 125441691 | 12544169 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |